The Low Carb Diabetic

Promoting a low carb high fat lifestyle for the safe control of diabetes. Eat whole fresh food, more drugs are not the answer.

Welcome to the Low Carb Diabetic forum,have you signed up yet? if not then sign up and join us in the low carb community today!

    FDA nixes Merck’s shot at getting Januvia cardio safety data onto the label


    Status :

    Male Posts : 3650
    Join date : 2014-08-10
    Location : Lancs

    FDA nixes Merck’s shot at getting Januvia cardio safety data onto the label

    Post by graham64 on Fri Apr 07 2017, 22:08

    Merck is not going to get any help from the FDA in marketing its big diabetes drug Januvia.

    A $6 billion earner last year, Merck’s flagship DPP-4 drug came out of a massive 14,724-patient study in 2015 with data demonstrating that Type 2 patients could take this drug without raising their risk for cardio complications. Merck wanted that in the label to help distinguish themselves from same-class rivals like Onglyza, which has risks, but the FDA nixed the idea, handing the pharma giant a complete response letter.

    The CRL covered Januvia as well as its combos with metformin.

    That has to be a bitter disappointment to Merck. Some solidly pro-Merck analysts like Tim Anderson were quick to give the TECOS cardio data a big thumbs up, estimating that it could swell revenue from the franchise drug by 10% by 2020. So far, though, instead of increasing, Januvia revenue has flattened out after SGLT2 drugs came along, GLP-1 drugs gained traction and new safety warnings hit the DPP-4 class.

    But Merck did not have a lot to say about it in their brief announcement this morning.

    Merck is reviewing the letter and will discuss next steps with the FDA.

    Sales groups for AstraZeneca’s $AZN Onglyza (saxagliptin) and Takeda’s Nesina have had to grapple with distinct evidence of safety risks, a tough rep to beat in the ultra competitive diabetes market, where marketers take advantage of everything they can reasonably lay their hands on.

    Check out the response letter in the link

    I'm a skinny T2 diagnosed 4/4/2008, a high calorie LCHF diet and one metformin a day A1c 6.2 and no complications.

    Proving the LowCarb sceptics wrong for over ten years

    Not all cherubs are Angels  Wink nor all diabetics Bonkers  Rolling Eyes
    chris c

    Status :

    Posts : 4362
    Join date : 2015-07-26

    Re: FDA nixes Merck’s shot at getting Januvia cardio safety data onto the label

    Post by chris c on Sun Apr 09 2017, 23:21

    Sounds really healthy stuff doesn't it?

      Current date/time is Thu Oct 18 2018, 11:02